. Step 21 of 41
Clinical Stem 1
Non-smoking female with a new right upper lobe lung mass and three PET-positive mediastinal lymph nodes

Question 6
To provide personalized therapy, this patient will most likely benefit from which of the following?
A. ALK-directed therapy


C. Folate analogue metabolic inhibitors
incorrect correct